“EFFICACY AND SAFETY OF CLADRIBINE: SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION IN HAIRY CELL LEUKEMIA PATIENTS”, Mediterr J Hematol Infect Dis, vol. 7, no. 1, p. e2015058, Oct. 2015, doi: 10.4084/mjhid.2015.058.